je.st
news
Lilly delays submission to market once-daily diabetes drug
2015-02-23 16:03:04| Biotech - Topix.net
Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter. REUTERS: Eli Lilly and Co said it would delay its application to market its once-daily diabetes treatment, basal insulin peglispro, beyond the current quarter.
Tags: market
drug
submission
delays
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||